Anticoagulant therapy support for colorectal cancer patients with blood clots
Part of Heart & circulation clinical trials.
This trial tests whether a medication therapy management (MTM) model helps make blood thinner treatment safer and more effective for colorectal cancer patients who have also developed dangerous blood clots. It aims to improve how well patients stick to their medication and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer and a confirmed blood clot (deep vein thrombosis or pulmonary embolism).
- You are currently taking or have taken blood thinners for your clot for at least 3 months.
- You are willing to continue active blood thinner treatment during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This trial tests a blood-thinning drug to prevent dangerous blood clots (venous thromboembolism) in people with colorectal cancer who are having surgery. It aims to see if the drug can help reduce clot risk safely.
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
Hear when a new Thrombosis, Venous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.